What is Dentsply Sirona Inc's earnings per share (EPS)?

Dentsply Sirona Inc (XRAY) reported diluted earnings per share of $-3.00 for fiscal year 2025. This represents a 33.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Dentsply Sirona Inc Financials

XRAY

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Dentsply Sirona Inc (XRAY) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 19 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 26/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Dentsply Sirona Inc has an operating margin of -11.5%, meaning the company retains $-11 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -23.2% the prior year.

Growth

Dentsply Sirona Inc's revenue declined 3% year-over-year, from $3.8B to $3.7B. This contraction results in a growth score of 28/100.

Leverage

Dentsply Sirona Inc carries a low D/E ratio of 1.50, meaning only $1.50 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 71/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Dentsply Sirona Inc's current ratio of 1.51 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 26/100, which could limit financial flexibility.

Cash Flow

Dentsply Sirona Inc has a free cash flow margin of 2.8%, earning a moderate score of 32/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Dentsply Sirona Inc generates a -44.7% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -46.9% the prior year.

Piotroski F-Score Neutral

5/9

Dentsply Sirona Inc passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed

-0.39x

For every $1 of reported earnings, Dentsply Sirona Inc generates $-0.39 in operating cash flow ($235.0M OCF vs -$598.0M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

-4.8x

Dentsply Sirona Inc earns $-4.8 in operating income for every $1 of interest expense (-$422.0M vs $88.0M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.7B

YoY-3.0%

5Y CAGR+2.0%

10Y CAGR+3.2%

Dentsply Sirona Inc generated $3.7B in revenue in fiscal year 2025. This represents a decrease of 3.0% from the prior year.

EBITDA

-$70.0M

YoY+86.8%

Dentsply Sirona Inc's EBITDA was -$70.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 86.8% from the prior year.

Net Income

-$598.0M

YoY+34.3%

Dentsply Sirona Inc reported -$598.0M in net income in fiscal year 2025. This represents an increase of 34.3% from the prior year.

EPS (Diluted)

$-3.00

YoY+33.0%

Dentsply Sirona Inc earned $-3.00 per diluted share (EPS) in fiscal year 2025. This represents an increase of 33.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$104.0M

YoY-63.0%

5Y CAGR-28.6%

10Y CAGR-13.1%

Dentsply Sirona Inc generated $104.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 63.0% from the prior year.

Cash & Debt

$326.0M

YoY+19.9%

5Y CAGR-5.7%

10Y CAGR+1.4%

Dentsply Sirona Inc held $326.0M in cash against $2.0B in long-term debt as of fiscal year 2025.

Dividends Per Share

$0.64

YoY+0.0%

5Y CAGR+9.9%

10Y CAGR+8.2%

Dentsply Sirona Inc paid $0.64 per share in dividends in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Shares Outstanding

200M

YoY+0.3%

5Y CAGR-1.8%

10Y CAGR+3.6%

Dentsply Sirona Inc had 200M shares outstanding in fiscal year 2025. This represents an increase of 0.3% from the prior year.

Margins & Returns

Gross Margin

50.0%

YoY-1.6pp

5Y CAGR+0.4pp

10Y CAGR-6.7pp

Dentsply Sirona Inc's gross margin was 50.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.6 percentage points from the prior year.

Operating Margin

-11.5%

YoY+11.7pp

5Y CAGR-11.4pp

10Y CAGR-25.5pp

Dentsply Sirona Inc's operating margin was -11.5% in fiscal year 2025, reflecting core business profitability. This is up 11.7 percentage points from the prior year.

Net Margin

-16.3%

YoY+7.7pp

5Y CAGR-14.1pp

10Y CAGR-25.6pp

Dentsply Sirona Inc's net profit margin was -16.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 7.7 percentage points from the prior year.

Return on Equity

-44.7%

YoY+2.2pp

5Y CAGR-43.2pp

10Y CAGR-55.4pp

Dentsply Sirona Inc's ROE was -44.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 2.2 percentage points from the prior year.

Capital Allocation

R&D Spending

$150.0M

YoY-9.1%

5Y CAGR+4.0%

10Y CAGR+7.2%

Dentsply Sirona Inc invested $150.0M in research and development in fiscal year 2025. This represents a decrease of 9.1% from the prior year.

Share Buybacks

YoY-100.0%

Dentsply Sirona Inc spent $0 on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 100.0% from the prior year.

Capital Expenditures

$131.0M

YoY-27.2%

5Y CAGR+8.5%

10Y CAGR+6.2%

Dentsply Sirona Inc invested $131.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 27.2% from the prior year.

XRAY Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$3.7B-3.0%	$3.8B-4.3%	$4.0B+1.1%	$3.9B-7.3%	$4.2B+26.7%	$3.3B
Cost of Revenue	$1.8B+0.3%	$1.8B-2.3%	$1.9B+4.7%	$1.8B-4.7%	$1.9B+11.9%	$1.7B
Gross Profit	$1.8B-6.0%	$2.0B-6.1%	$2.1B-1.9%	$2.1B-9.4%	$2.3B+41.7%	$1.7B
R&D Expenses	$150.0M-9.1%	$165.0M-10.3%	$184.0M+5.7%	$174.0M+1.8%	$171.0M+39.0%	$123.0M
SG&A Expenses	$1.4B-10.4%	$1.6B-0.5%	$1.6B+1.5%	$1.6B+2.5%	$1.6B+19.1%	$1.3B
Operating Income	-$422.0M+52.0%	-$879.0M-934.1%	-$85.0M+90.9%	-$937.0M-254.1%	$608.0M+20366.7%	-$3.0M
Interest Expense	$88.0M+27.5%	$69.0M-14.8%	$81.0M+24.6%	$65.0M+6.6%	$61.0M+27.1%	$48.0M
Income Tax	$112.0M+530.8%	-$26.0M+39.5%	-$43.0M+59.0%	-$105.0M-178.4%	$134.0M+482.6%	$23.0M
Net Income	-$598.0M+34.3%	-$910.0M-589.4%	-$132.0M+86.1%	-$950.0M-331.1%	$411.0M+663.0%	-$73.0M
EPS (Diluted)	$-3.00+33.0%	$-4.48-622.6%	$-0.62+85.9%	$-4.41-335.8%	$1.87+666.7%	$-0.33

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$961.0M+6.3%	$904.0M-3.4%	$936.0M+6.5%	$879.0M-2.9%	$905.0M-4.8%	$951.0M-3.4%	$984.0M+3.3%	$953.0M
Cost of Revenue	$518.0M+11.9%	$463.0M+3.8%	$446.0M+8.0%	$413.0M-10.0%	$459.0M+0.7%	$456.0M-3.6%	$473.0M+5.8%	$447.0M
Gross Profit	$443.0M+0.5%	$441.0M-10.0%	$490.0M+5.2%	$466.0M+4.5%	$446.0M-9.9%	$495.0M-3.1%	$511.0M+1.0%	$506.0M
R&D Expenses	$40.0M+8.1%	$37.0M0.0%	$37.0M+2.8%	$36.0M-14.3%	$42.0M+5.0%	$40.0M-2.4%	$41.0M-2.4%	$42.0M
SG&A Expenses	$383.0M+7.9%	$355.0M+3.8%	$342.0M-4.5%	$358.0M-10.7%	$401.0M+2.8%	$390.0M-2.3%	$399.0M-3.9%	$415.0M
Operating Income	-$139.0M+36.2%	-$218.0M-70.3%	-$128.0M-303.2%	$63.0M+112.4%	-$509.0M-10.2%	-$462.0M-1024.0%	$50.0M+19.0%	$42.0M
Interest Expense	$22.0M-4.3%	$23.0M-4.2%	$24.0M+26.3%	$19.0M+18.8%	$16.0M-11.1%	$18.0M+5.9%	$17.0M-5.6%	$18.0M
Income Tax	-$2.0M-101.0%	$198.0M+281.7%	-$109.0M-536.0%	$25.0M+126.3%	-$95.0M-658.8%	$17.0M-55.3%	$38.0M+171.4%	$14.0M
Net Income	-$146.0M+65.8%	-$427.0M-848.9%	-$45.0M-325.0%	$20.0M+104.7%	-$430.0M+13.0%	-$494.0M-12250.0%	-$4.0M-122.2%	$18.0M
EPS (Diluted)	N/A	$-2.14-872.7%	$-0.22-320.0%	$0.10	N/A	$-2.46-12200.0%	$-0.02-122.2%	$0.09

XRAY Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$5.4B-5.6%	$5.8B-21.9%	$7.4B-3.6%	$7.6B-17.3%	$9.2B-1.2%	$9.3B
Current Assets	$2.0B+15.9%	$1.7B-11.5%	$2.0B+4.2%	$1.9B+2.2%	$1.9B+3.0%	$1.8B
Cash & Equivalents	$326.0M+19.9%	$272.0M-18.6%	$334.0M-8.5%	$365.0M+7.7%	$339.0M-22.6%	$438.0M
Inventory	$642.0M+13.8%	$564.0M-9.6%	$624.0M-0.5%	$627.0M+21.7%	$515.0M+8.2%	$476.0M
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$1.1B-28.1%	$1.6B-34.5%	$2.4B-9.3%	$2.7B-32.4%	$4.0B-0.3%	$4.0B
Total Liabilities	$4.1B+7.3%	$3.8B-6.5%	$4.1B+6.4%	$3.8B-9.7%	$4.2B-3.9%	$4.4B
Current Liabilities	$1.3B-15.5%	$1.6B+11.5%	$1.4B+21.8%	$1.2B-7.2%	$1.3B-8.1%	$1.4B
Long-Term Debt	$2.0B+27.0%	$1.6B-11.7%	$1.8B-1.6%	$1.8B-4.5%	$1.9B-3.3%	$2.0B
Total Equity	$1.3B-31.1%	$1.9B-41.0%	$3.3B-13.6%	$3.8B-23.7%	$5.0B+1.3%	$4.9B
Retained Earnings	-$1.6B-87.3%	-$835.0M-507.3%	$205.0M-55.0%	$456.0M-69.9%	$1.5B+26.4%	$1.2B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$5.4B-4.0%	$5.7B-6.9%	$6.1B+0.3%	$6.0B+5.2%	$5.8B-13.2%	$6.6B-3.9%	$6.9B-3.2%	$7.1B
Current Assets	$2.0B-2.4%	$2.1B+5.4%	$2.0B-0.6%	$2.0B+13.3%	$1.7B-9.1%	$1.9B+9.3%	$1.8B-7.6%	$1.9B
Cash & Equivalents	$326.0M-10.2%	$363.0M+1.1%	$359.0M-9.8%	$398.0M+46.3%	$272.0M-8.1%	$296.0M+6.1%	$279.0M-4.1%	$291.0M
Inventory	$642.0M-6.4%	$686.0M+1.6%	$675.0M+10.3%	$612.0M+8.5%	$564.0M-8.9%	$619.0M+1.8%	$608.0M-0.8%	$613.0M
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$1.1B-9.6%	$1.3B-16.9%	$1.5B-6.4%	$1.6B+2.2%	$1.6B-17.6%	$1.9B-18.9%	$2.4B-0.5%	$2.4B
Total Liabilities	$4.1B-2.1%	$4.2B+1.6%	$4.1B+1.7%	$4.0B+6.0%	$3.8B-7.9%	$4.1B+7.9%	$3.8B-0.8%	$3.9B
Current Liabilities	$1.3B-4.4%	$1.4B+20.5%	$1.2B-35.0%	$1.8B+12.8%	$1.6B+3.0%	$1.5B+16.6%	$1.3B-0.5%	$1.3B
Long-Term Debt	$2.0B-0.1%	$2.0B-9.1%	$2.2B+39.2%	$1.6B+0.4%	$1.6B-11.6%	$1.8B+3.3%	$1.7B-0.6%	$1.7B
Total Equity	$1.3B-9.4%	$1.5B-24.6%	$2.0B-2.5%	$2.0B+3.5%	$1.9B-22.0%	$2.5B-18.7%	$3.1B-6.0%	$3.3B
Retained Earnings	-$1.6B-12.9%	-$1.4B-49.7%	-$925.0M-9.1%	-$848.0M-1.6%	-$835.0M-123.3%	-$374.0M-346.1%	$152.0M-20.0%	$190.0M

XRAY Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$235.0M-49.0%	$461.0M+22.3%	$377.0M-27.1%	$517.0M-21.3%	$657.0M+1.2%	$649.0M
Capital Expenditures	$131.0M-27.2%	$180.0M+20.8%	$149.0M0.0%	$149.0M+4.9%	$142.0M+63.2%	$87.0M
Free Cash Flow	$104.0M-63.0%	$281.0M+23.2%	$228.0M-38.0%	$368.0M-28.5%	$515.0M-8.4%	$562.0M
Investing Cash Flow	-$132.0M+33.0%	-$197.0M-121.3%	-$89.0M+35.5%	-$138.0M+61.5%	-$358.0M+67.6%	-$1.1B
Financing Cash Flow	-$80.0M+73.5%	-$302.0M+1.6%	-$307.0M+6.7%	-$329.0M+13.2%	-$379.0M-179.6%	$476.0M
Dividends Paid	$128.0M+1.6%	$126.0M+8.6%	$116.0M+11.5%	$104.0M+13.0%	$92.0M+4.5%	$88.0M
Share Buybacks	$0-100.0%	$250.0M-16.7%	$300.0M+100.0%	$150.0M-25.0%	$200.0M+42.9%	$140.0M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$101.0M+27.8%	$79.0M+64.6%	$48.0M+585.7%	$7.0M-92.0%	$87.0M-38.3%	$141.0M-32.2%	$208.0M+732.0%	$25.0M
Capital Expenditures	$41.0M+5.1%	$39.0M+21.9%	$32.0M+68.4%	$19.0M-62.7%	$51.0M+18.6%	$43.0M-17.3%	$52.0M+52.9%	$34.0M
Free Cash Flow	$60.0M+50.0%	$40.0M+150.0%	$16.0M+233.3%	-$12.0M-133.3%	$36.0M-63.3%	$98.0M-37.2%	$156.0M+1833.3%	-$9.0M
Investing Cash Flow	-$45.0M-25.0%	-$36.0M-5.9%	-$34.0M-100.0%	-$17.0M+70.2%	-$57.0M-21.3%	-$47.0M+6.0%	-$50.0M-16.3%	-$43.0M
Financing Cash Flow	-$99.0M-175.0%	-$36.0M+47.1%	-$68.0M-155.3%	$123.0M+423.7%	-$38.0M+51.9%	-$79.0M+53.8%	-$171.0M-1121.4%	-$14.0M
Dividends Paid	$32.0M0.0%	$32.0M0.0%	$32.0M0.0%	$32.0M+3.2%	$31.0M-6.1%	$33.0M0.0%	$33.0M+13.8%	$29.0M
Share Buybacks	$0	$0	N/A	N/A	$0-100.0%	$100.0M-33.3%	$150.0M	$0

XRAY Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	50.0%-1.6pp	51.6%-1.0pp	52.6%-1.6pp	54.2%-1.2pp	55.5%+5.9pp	49.6%
Operating Margin	-11.5%+11.7pp	-23.2%-21.0pp	-2.1%+21.8pp	-23.9%-38.3pp	14.4%+14.5pp	-0.1%
Net Margin	-16.3%+7.7pp	-24.0%-20.7pp	-3.3%+20.9pp	-24.2%-33.9pp	9.7%+11.9pp	-2.2%
Return on Equity	-44.7%+2.2pp	-46.9%-42.9pp	-4.0%+20.9pp	-24.9%-33.2pp	8.2%+9.7pp	-1.5%
Return on Assets	-11.0%+4.8pp	-15.8%-14.0pp	-1.8%+10.6pp	-12.4%-16.9pp	4.5%+5.2pp	-0.8%
Current Ratio	1.51+0.4	1.10-0.3	1.38-0.2	1.62+0.1	1.47+0.2	1.31
Debt-to-Equity	1.50+0.7	0.82+0.3	0.55+0.1	0.48+0.1	0.38-0.0	0.40
FCF Margin	2.8%-4.6pp	7.4%+1.7pp	5.8%-3.6pp	9.4%-2.8pp	12.2%-4.7pp	16.8%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	46.1%-2.7pp	48.8%-3.6pp	52.3%-0.7pp	53.0%+3.7pp	49.3%-2.8pp	52.0%+0.1pp	51.9%-1.2pp	53.1%
Operating Margin	-14.5%+9.7pp	-24.1%-10.4pp	-13.7%-20.9pp	7.2%+63.4pp	-56.2%-7.7pp	-48.6%-53.7pp	5.1%+0.7pp	4.4%
Net Margin	-15.2%+32.0pp	-47.2%-42.4pp	-4.8%-7.1pp	2.3%+49.8pp	-47.5%+4.4pp	-51.9%-51.5pp	-0.4%-2.3pp	1.9%
Return on Equity	-10.9%+18.0pp	-28.9%-26.6pp	-2.3%-3.3pp	1.0%+23.1pp	-22.1%-2.3pp	-19.8%-19.7pp	-0.1%-0.7pp	0.5%
Return on Assets	-2.7%+4.9pp	-7.5%-6.8pp	-0.7%-1.1pp	0.3%+7.8pp	-7.5%-0.0pp	-7.5%-7.4pp	-0.1%-0.3pp	0.3%
Current Ratio	1.51+0.0	1.47-0.2	1.69+0.6	1.100.0	1.10-0.1	1.25-0.1	1.33-0.1	1.43
Debt-to-Equity	1.50+0.1	1.36+0.2	1.13+0.3	0.79-0.0	0.82+0.1	0.72+0.2	0.57+0.0	0.54
FCF Margin	6.2%+1.8pp	4.4%+2.7pp	1.7%+3.1pp	-1.4%-5.4pp	4.0%-6.3pp	10.3%-5.6pp	15.8%+16.8pp	-0.9%

Similar Companies

Envista Holdings Corp NVST

$4.2B

Warby Parker Inc WRBY

$2.5B

Lemaitre Vasculr LMAT

$2.5B

Icu Medical ICUI

$3.0B

Merit Med Sys Inc MMSI

$4.0B

Frequently Asked Questions

What is Dentsply Sirona Inc's annual revenue?

Dentsply Sirona Inc (XRAY) reported $3.7B in total revenue for fiscal year 2025. This represents a -3.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Dentsply Sirona Inc's revenue growing?

Dentsply Sirona Inc (XRAY) revenue declined by 3% year-over-year, from $3.8B to $3.7B in fiscal year 2025.

Is Dentsply Sirona Inc profitable?

No, Dentsply Sirona Inc (XRAY) reported a net income of -$598.0M in fiscal year 2025, with a net profit margin of -16.3%.

What is Dentsply Sirona Inc's EBITDA?

Dentsply Sirona Inc (XRAY) had EBITDA of -$70.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Dentsply Sirona Inc have?

As of fiscal year 2025, Dentsply Sirona Inc (XRAY) had $326.0M in cash and equivalents against $2.0B in long-term debt.

What is Dentsply Sirona Inc's gross margin?

Dentsply Sirona Inc (XRAY) had a gross margin of 50.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Dentsply Sirona Inc's operating margin?

Dentsply Sirona Inc (XRAY) had an operating margin of -11.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Dentsply Sirona Inc's net profit margin?

Dentsply Sirona Inc (XRAY) had a net profit margin of -16.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Dentsply Sirona Inc pay dividends?

Yes, Dentsply Sirona Inc (XRAY) paid $0.64 per share in dividends during fiscal year 2025.

What is Dentsply Sirona Inc's return on equity (ROE)?

Dentsply Sirona Inc (XRAY) has a return on equity of -44.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Dentsply Sirona Inc's free cash flow?

Dentsply Sirona Inc (XRAY) generated $104.0M in free cash flow during fiscal year 2025. This represents a -63.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Dentsply Sirona Inc's operating cash flow?

Dentsply Sirona Inc (XRAY) generated $235.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Dentsply Sirona Inc's total assets?

Dentsply Sirona Inc (XRAY) had $5.4B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Dentsply Sirona Inc's capital expenditures?

Dentsply Sirona Inc (XRAY) invested $131.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Dentsply Sirona Inc spend on research and development?

Dentsply Sirona Inc (XRAY) invested $150.0M in research and development during fiscal year 2025.

How many shares does Dentsply Sirona Inc have outstanding?

Dentsply Sirona Inc (XRAY) had 200M shares outstanding as of fiscal year 2025.

What is Dentsply Sirona Inc's current ratio?

Dentsply Sirona Inc (XRAY) had a current ratio of 1.51 as of fiscal year 2025, which is generally considered healthy.

What is Dentsply Sirona Inc's debt-to-equity ratio?

Dentsply Sirona Inc (XRAY) had a debt-to-equity ratio of 1.50 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Dentsply Sirona Inc's return on assets (ROA)?

Dentsply Sirona Inc (XRAY) had a return on assets of -11.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Dentsply Sirona Inc's Piotroski F-Score?

Dentsply Sirona Inc (XRAY) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Dentsply Sirona Inc's earnings high quality?

Dentsply Sirona Inc (XRAY) has an earnings quality ratio of -0.39x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Dentsply Sirona Inc cover its interest payments?

Dentsply Sirona Inc (XRAY) has an interest coverage ratio of -4.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Dentsply Sirona Inc?

Dentsply Sirona Inc (XRAY) scores 26 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.